Project Grant R01DK140854

Award Date 8/1/24
Completion Date 5/31/29
Dollars Obligated $637K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48824, USA
Similar Awards
This $241,130 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research at the University of Michigan to study adaptive responses to a complete thyroglobulin gene knockout. The award has an ultimate completion date of March 31, 2027 and was granted on August 16, 2024. The Diabetes, Digestive, and Kidney Diseases Extramural Research program...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will provide $516,648 over the period of Aug 28, 2024 to Feb 28, 2027 to The Leland Stanford Junior University to conduct research on understanding the mechanisms by which microbially-derived metabolites regulate host gut inflammation. The key products/services to be delivered under this award...
This Project Grant award, totaling $233,600.00 and spanning September 1, 2024 to June 30, 2027, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports high-throughput functional analyses of genetic drivers of inflammatory bowel disease (IBD), a debilitating condition characterized by chronic inflammation and erosion of intestinal functions. The...
The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $222,500 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Beckman Research Institute of the City of Hope. The grant supports research to understand how conjugated bile acids regulate metabolism after bariatric surgery, with the goal of developing safer and more affordable treatments for obesity and fatty liver disease. Key activities include...
This $2,041,139 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to understand the mechanisms regulating epithelial-mesenchymal crosstalk during intrahepatic bile duct (IHBD) development. The project aims to define the roles of the GLI1 periportal mesenchyme and epithelial Indian Hedgehog (IHH) in regulating epithelial-periportal mesenchymal...
This Project Grant award, totaling $216,736.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project aims to identify the mechanisms by which the host circadian clock and gut microbiome regulate mucus production in the large intestine to protect against infectious and chemical colitis. Key objectives include determining the specific microbiota...
This federal Project Grant award of $224,088.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to elucidate the mechanisms of Notch signaling in intestinal stem cells. The key objectives are to: 1) define the Notch signaling niche for intestinal stem cells throughout development, and 2) investigate how intestinal stem cells provide...
This Project Grant award, worth $492,409, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award aims to evaluate the role of the creatine pathway in regulating intestinal goblet cell development and its impact on the microbiome and susceptibility to colitis. Specifically, the research will investigate the contribution of glycolysis on goblet cell...
This federal Project Grant award in the amount of $640,762.00 was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, with a start date of September 15, 2024 and an ultimate completion date of June 30, 2029, will fund research conducted by the Scripps Research Institute in La Jolla, California to investigate the interorgan communication mechanisms between...
The University of Chicago was awarded a $984,000 cooperative agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a cross-sectional and longitudinal study on the role of gut microbiota in Parkinson's disease (PD). The study aims to gain a better understanding of how gut dysbiosis may contribute to the development, progression, and prognosis of PD, with...

This federal Project Grant award of $637,000.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to explore the production and signaling properties of novel bile acids produced by the gut microbiome. The project aims to 1) define the microbiology of microbially conjugated bile acid (MCBA) production, 2) determine the agonist activity of MCBAs on the ileal receptor FXR in vitro and in vivo, and 3) assess the impact of MCBAs on outcomes in a mouse model of gastrointestinal inflammation. The award includes a sub-grant of an unspecified amount to the University of Michigan to conduct cell culture experiments and RNA sequencing analysis related to the project. The grant has an award date of Aug 1, 2024 and an ultimate completion date of May 31, 2029.

Generated 7/1/25, 4:53 AM